Administration of doxorubicin increases the sensitivity of the mitochondrial permeability transition pore to calcium and causes pathological changes in the electrocardiography.

Back

HFA Premium Access

Administration of doxorubicin increases the sensitivity of the mitochondrial permeability transition pore to calcium and causes pathological changes in the electrocardiography.

Session: ePosters in chronic heart failure - pathophysiology and mechanisms 2

Topic: Cardiotoxicity of Drugs and Other Therapies

Speaker: Mrs M. Denysova (Kiev, UA)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Mrs Maiia Denysova

Bogomoletz Institute of Physiology, Kiev (Ukraine)

0 follower

6 more presentations in this session

Evolution of pericardial effusion in cancer patients

Speaker: Doctor M. Fernandez Garcia (Oviedo, ES)

Access

Abstract

Slides

Cancer incidence and mortality in patients diagnosed with heart failure: results from an updated systematic review and meta-analysis.

Speaker: Doctor M. Camilli (Rome, IT)

Access

Abstract

Slides

Cardiac events in patients with acute myeloid leukaemia after intensive chemotherapy

Speaker: Doctor P. Kleitsioti (Thessaloniki, GR)

Access

Abstract

Slides

The role of natriuretic peptide as an early predictor of subclinical anthracycline therapy related cardiotoxicity

Speaker: Professor D. Zaliaduonyte (Kaunas, LT)

Access

Abstract

Slides

Heamodynamics in patients with heart failure and atrial fibrillation: accent on the left and right atriums

Speaker: Associate Professor D. Shorikova (Chernivtsi, UA)

Access

Abstract

Slides

Access the full session

ePosters in chronic heart failure - pathophysiology and mechanisms 2

Speakers: Mrs M. Denysova, Doctor M. Fernandez Garcia, Doctor M. Camilli, Doctor P. Kleitsioti, Professor D. Zaliaduonyte...

Access

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources